Rezolute develops novel therapeutic products for the diabetes market.
Auxulin Pharmaceuticals is a specialty pharmaceutical company seeking to augment traditional insulin therapy used in the treatment of diabetes.
Zafgen is a biopharmaceutical company dedicated to improving the health and well-being of patients affected by obesity and complex metabolic disorders.
Araim Pharmaceuticals is a company focused on the discovery of a global master regulator, the Innate Repair Receptors (IRR), that produces cellular and tissue repair in various disease states.
Diabetology is a clinical-stage biopharmaceutical company.
Louisville, US HQ
Redwood City, US
Chesterland, US HQ
Boston, US HQ
Saint Helier, GB HQ
Valuation ($)54.3 m
Valuation ($)3.1 m
Net income($20.3m) (FY, 2020)
Net income($42.5m) (FY, 2020)